Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

The future of cancer treatment – combining stem cells and immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Biotech Daily reports ….. Professor Jacques Miller wins Japan prize, January 2018

By carth_admin / May 31, 2018
Professor Jacques Miller a member of Cartherics’ Scientific Advisory Board  wins “The Japan Prize Foundation says Walter and Eliza Hall...
Read More

Miltenyi Biotec News ANZ Newsletter : Spring/ Summer 2017

By carth_admin / May 31, 2018
Immunotherapy : Professor Alan Trounson and Professor Richard Boyd started the future of cancer treatment at the Monash Health Translation Precinct.
Read More

Lifesaving ‘off-the-shelf’ cancer tracking immunotherapies underway

By carth_admin / May 30, 2018
29 May 2018, Hudson Institute of Medical Research ‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and...
Read More